Despite the challenges associated with studying exosomes due to their low abundance, small size, and fragility, they are ...

Cancer ranks as one of the top causes of death worldwide. The National Cancer Institute reported nearly 20 million new cancer ...

Many diseases are caused by a missing or defective copy of a single gene. For decades, scientists have been working on gene ...

Natural killer cells aren't just mindless defenders — a special type, adaptive NK cells, remember their enemies and come back ...

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during ...

New research shows 92% of cancer patients stayed cancer-free for two years after immune-based therapy, potentially avoiding surgery and harsh treatments.

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Cancer operations that remove whole or parts of an organ can be life-altering. New research suggests that some patients may ...

Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, today announced three presentations that underscore ...

Immune checkpoint inhibitor-based combinations have become the preferred first-line therapy for patients with metastatic clear cell renal cell carcinoma, but more than a third of eligible patients do ...

Many diseases are caused by a missing or defective copy of a single gene. For decades, scientists have been working on gene ...

Banning mRNA technology in response to the many missteps of public health officials during the pandemic is a textbook example of cutting off one’s nose to spite one’s face. | Opinion ...